Pub Date : 2023-05-31DOI: 10.4274/imj.galenos.2023.23356
Bilge Gökçe, E. Aytekin, Y. Pekin Doğan, Didem İnceboy, Ertan Yüce, Fatma Ustabaşıoğlu
to the initial state (p<0.05). The improvement in these scores was higher in the treatment group than in the control group in the first and the second months both (p<0.05). Conclusion: These findings confirm that LLLT is an effective and reliable therapy choice in the conservative management of PF.
{"title":"Effectiveness of Low-Level Laser Therapy in Chronic Plantar Fasciitis Conservative Treatment","authors":"Bilge Gökçe, E. Aytekin, Y. Pekin Doğan, Didem İnceboy, Ertan Yüce, Fatma Ustabaşıoğlu","doi":"10.4274/imj.galenos.2023.23356","DOIUrl":"https://doi.org/10.4274/imj.galenos.2023.23356","url":null,"abstract":"to the initial state (p<0.05). The improvement in these scores was higher in the treatment group than in the control group in the first and the second months both (p<0.05). Conclusion: These findings confirm that LLLT is an effective and reliable therapy choice in the conservative management of PF.","PeriodicalId":42584,"journal":{"name":"Istanbul Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42882454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-31DOI: 10.4274/imj.galenos.2023.98370
A. Sarici, M. Erkurt, I. Kuku, E. Kaya, İ. Berber, S. Biçim, Emine Hidayet, Ahmet Kaya, Ömer Faruk Bahçecíoğlu, L. Tanrıverdi, S. Özkan
allo-HSCT
{"title":"The Experience of Ibrutinib in Chronic Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience","authors":"A. Sarici, M. Erkurt, I. Kuku, E. Kaya, İ. Berber, S. Biçim, Emine Hidayet, Ahmet Kaya, Ömer Faruk Bahçecíoğlu, L. Tanrıverdi, S. Özkan","doi":"10.4274/imj.galenos.2023.98370","DOIUrl":"https://doi.org/10.4274/imj.galenos.2023.98370","url":null,"abstract":"allo-HSCT","PeriodicalId":42584,"journal":{"name":"Istanbul Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49399265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-31DOI: 10.4274/imj.galenos.2023.88122
S. Erdem, R. U. Gürsu, M. Ergüney, M. Ar
setting, the Khorana score failed to differentiate the target population. This could be partly explained by the heterogeneity and the relatively small number of patients included.
Khorana评分未能区分目标人群。这可以部分解释为异质性和所包括的患者数量相对较少。
{"title":"Evaluation of Thromboembolism Risk in Patients with Cancer; Single Center Real-life Data","authors":"S. Erdem, R. U. Gürsu, M. Ergüney, M. Ar","doi":"10.4274/imj.galenos.2023.88122","DOIUrl":"https://doi.org/10.4274/imj.galenos.2023.88122","url":null,"abstract":"setting, the Khorana score failed to differentiate the target population. This could be partly explained by the heterogeneity and the relatively small number of patients included.","PeriodicalId":42584,"journal":{"name":"Istanbul Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49359866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-31DOI: 10.4274/imj.galenos.2023.70952
Eyüp Murat Kanber, Mehmet Köseoğlu
were shared by professional healthcare providers had significantly higher modified DISCERN score, GQS, and PEMAT score.
与专业医疗保健提供者共享的患者具有更高的修改后的DISCERN评分、GQS和PEMAT评分。
{"title":"Evaluation of YouTube Videos Quality of Pediatric Cardiac Surgery Anesthesia","authors":"Eyüp Murat Kanber, Mehmet Köseoğlu","doi":"10.4274/imj.galenos.2023.70952","DOIUrl":"https://doi.org/10.4274/imj.galenos.2023.70952","url":null,"abstract":"were shared by professional healthcare providers had significantly higher modified DISCERN score, GQS, and PEMAT score.","PeriodicalId":42584,"journal":{"name":"Istanbul Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43622140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-31DOI: 10.4274/imj.galenos.2023.06253
Yaşar Gökhan Gül, Ali Haspolat, Halil Can Canatan, Ali Şefik Köprülü, Emine Uzunoğlu
Postoperative nausea and vomiting (PONV) is a significant complication that affects patient comfort, with an average rate of 30% in surgical patients and up to 80% in the high-risk groups (1). This condition can be extremely stressful and is directly associated with patient satisfaction. It may further lead to additional problems such as significantly longer postanesthesia care unit stays, unexpected hospitalization of outpatients, impaired surgical success, and increased healthcare costs (1).
{"title":"Comparison of the Effects of Pharyngeal Packing and Gastric Aspiration with an Orogastric Tube on Postoperative Nausea, Vomiting and Sore Throat in Septorhinoplasty","authors":"Yaşar Gökhan Gül, Ali Haspolat, Halil Can Canatan, Ali Şefik Köprülü, Emine Uzunoğlu","doi":"10.4274/imj.galenos.2023.06253","DOIUrl":"https://doi.org/10.4274/imj.galenos.2023.06253","url":null,"abstract":"Postoperative nausea and vomiting (PONV) is a significant complication that affects patient comfort, with an average rate of 30% in surgical patients and up to 80% in the high-risk groups (1). This condition can be extremely stressful and is directly associated with patient satisfaction. It may further lead to additional problems such as significantly longer postanesthesia care unit stays, unexpected hospitalization of outpatients, impaired surgical success, and increased healthcare costs (1).","PeriodicalId":42584,"journal":{"name":"Istanbul Medical Journal","volume":"1 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70872389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-31DOI: 10.4274/imj.galenos.2023.86143
H. Turan, I. Kahramanoglu, Ulviyya Alakbarova, Kubra Hamzaoglu, T. Beşe, M. Arvas, F. Demirkıran
933; p=0.039; OR: 0.002; 95% CI: 0.001-0.025; p=0.001; OR: 0.217; 95% CI: 0.082-0.577; p=0.002; OR: 0.033; 95% CI: 0.003-0.379; p=0.006, respectively]. Conclusion: We suggest that every patient undergoing gynecological oncology surgery should have preoperative pharmacological and postoperative extended dual prophylaxis to achieve the lowest incidence of VTE in this group.
{"title":"Incidence and Risk Factors of Venous Thromboembolism in Patients Undergoing Surgery for Gynecologic Malignancies","authors":"H. Turan, I. Kahramanoglu, Ulviyya Alakbarova, Kubra Hamzaoglu, T. Beşe, M. Arvas, F. Demirkıran","doi":"10.4274/imj.galenos.2023.86143","DOIUrl":"https://doi.org/10.4274/imj.galenos.2023.86143","url":null,"abstract":"933; p=0.039; OR: 0.002; 95% CI: 0.001-0.025; p=0.001; OR: 0.217; 95% CI: 0.082-0.577; p=0.002; OR: 0.033; 95% CI: 0.003-0.379; p=0.006, respectively]. Conclusion: We suggest that every patient undergoing gynecological oncology surgery should have preoperative pharmacological and postoperative extended dual prophylaxis to achieve the lowest incidence of VTE in this group.","PeriodicalId":42584,"journal":{"name":"Istanbul Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42201450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-31DOI: 10.4274/imj.galenos.2023.38387
U. Binay, F. Karakeçili, Orçun Barkay, Özlem Gül
(P)/ritonavir (R)/dasabuvir and OBV/P/R/ribavirin in 76.5% (n=39) appears to be used. A statistically significant difference was found between the alanine aminotransferase, aspartate aminotransferase measurements, and platelet counts of the subjects participating in the study at the beginning, at the 4 th week, at the end of the treatment, and at the 12 th week (p=0.001). In these cases, a sustained virological response was achieved in 100%. In the follow-up of the cases, no serious side effects that required drug discontinuation were observed. Conclusion: Our study showed that the treatment success of DAAs is 100% and their side-effect profiles are good.
{"title":"Real-Life Data of Chronic Hepatitis C Patients Treated with Direct-Acting Oral Antivirals: A Single-Center Study","authors":"U. Binay, F. Karakeçili, Orçun Barkay, Özlem Gül","doi":"10.4274/imj.galenos.2023.38387","DOIUrl":"https://doi.org/10.4274/imj.galenos.2023.38387","url":null,"abstract":"(P)/ritonavir (R)/dasabuvir and OBV/P/R/ribavirin in 76.5% (n=39) appears to be used. A statistically significant difference was found between the alanine aminotransferase, aspartate aminotransferase measurements, and platelet counts of the subjects participating in the study at the beginning, at the 4 th week, at the end of the treatment, and at the 12 th week (p=0.001). In these cases, a sustained virological response was achieved in 100%. In the follow-up of the cases, no serious side effects that required drug discontinuation were observed. Conclusion: Our study showed that the treatment success of DAAs is 100% and their side-effect profiles are good.","PeriodicalId":42584,"journal":{"name":"Istanbul Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44034432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-31DOI: 10.4274/imj.galenos.2023.09334
Emre Şancı, Asım Enes Özbek, Furkan Alkan, Hikmet Kılınç, H. C. Halhalli
had no significant difference for 1,3 and 12-month mortality (p=0.142, 0.280, 0.351 respectively). Conclusion: The patients admitted to the hospital via the emergency department had no mortality difference between different neutrophil levels or hematologic phenotypes. Further studies are required to assess cutoff values of blood neutrophil counts as an independent biomarker.
{"title":"Comparison of Hematological Phenotypes of COPD Exacerbations in Hospitalized Patients after Emergency Department Admission","authors":"Emre Şancı, Asım Enes Özbek, Furkan Alkan, Hikmet Kılınç, H. C. Halhalli","doi":"10.4274/imj.galenos.2023.09334","DOIUrl":"https://doi.org/10.4274/imj.galenos.2023.09334","url":null,"abstract":"had no significant difference for 1,3 and 12-month mortality (p=0.142, 0.280, 0.351 respectively). Conclusion: The patients admitted to the hospital via the emergency department had no mortality difference between different neutrophil levels or hematologic phenotypes. Further studies are required to assess cutoff values of blood neutrophil counts as an independent biomarker.","PeriodicalId":42584,"journal":{"name":"Istanbul Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48264488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-31DOI: 10.4274/imj.galenos.2023.66742
I. Serin, M. Doğu, Ömer Ekinci, Gülsüm Akgün Çağlıyan, A. Baştürk, M. Aras, Sinan Demircioğlu, B. Turgut, M. Merter, S. Kabukçu Hacıoğlu, M. Bagci, M. Albayrak, S. Korkmaz, M. Erkurt, M. Dal, F. Ersoy Dursun, A. Tombak, İ. Aydoğdu, T. Ulaş, F. Altuntaş
Cite this article as: Serin İ, Doğu MH, Ekinci Ö, Akgün Çağlıyan G, Baştürk A, Aras MR, Demircioğlu S, Turgut B, Merter M, Kabukçu Hacıoğlu S, Bağcı M, Albayrak M, Korkmaz S, Erkurt MA, Dal MS, Ersoy Dursun F, Tombak A, Aydoğdu İ, Ulaş T, Altuntaş F. A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera. İstanbul Med J 2023; 24(2): 120-5. 1University of Health Sciences Turkey, İstanbul Training and Research Hospital, Clinic of Hematology, İstanbul, Turkey 2İstinye University, Liv Hospital Ulus, Clinic of Hematology, İstanbul, Turkey 3University of Health Sciences Turkey, Gazi Yaşargil Training and Research Hospital, Clinic of Hematology, Diyarbakır, Turkey 4Pamukkale University Faculty of Medicine, Department of Hematology, Denizli, Turkey 5Medicana International İstanbul Hospital, İstanbul, Turkey 6University of Health Sciences Turkey, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Clinic of Hematology, Ankara, Turkey 7Necmettin Erbakan University, Meram Faculty of Medicine, Department of Hematology, Konya, Turkey 8Namık Kemal University Faculty of Medicine, Department of Hematology, Tekirdağ, Turkey 9Fırat University Faculty of Medicine, Department of Hematology, Elazığ, Turkey 10Selçuk University Faculty of Medicine, Department of Hematology, Konya, Turkey 11University of Health Sciences Turkey, Kayseri City Training and Research Hospital, Clinic of Hematology and Apheresis Unit, Kayseri, Turkey 12İnönü University Faculty of Medicine, Department of Hematology, Malatya, Turkey 13University of Health Sciences Turkey, Ankara Oncology Training and Research Hospital, Clinic of Hematology and Apheresis Unit, Ankara, Turkey 14İstanbul Medeniyet University, Göztepe Training and Research Hospital, Clinic of Hematology, İstanbul, Turkey 15Mersin University Faculty of Medicine, Department of Hematology, Mersin, Turkey 16Manisa Celal Bayar University Faculty of Medicine, Department of Hematology, Manisa, Turkey 17Near East University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Lefkoşa, Cyprus 18Ankara Yıldırım Beyazıt University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Turkey
{"title":"A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera","authors":"I. Serin, M. Doğu, Ömer Ekinci, Gülsüm Akgün Çağlıyan, A. Baştürk, M. Aras, Sinan Demircioğlu, B. Turgut, M. Merter, S. Kabukçu Hacıoğlu, M. Bagci, M. Albayrak, S. Korkmaz, M. Erkurt, M. Dal, F. Ersoy Dursun, A. Tombak, İ. Aydoğdu, T. Ulaş, F. Altuntaş","doi":"10.4274/imj.galenos.2023.66742","DOIUrl":"https://doi.org/10.4274/imj.galenos.2023.66742","url":null,"abstract":"Cite this article as: Serin İ, Doğu MH, Ekinci Ö, Akgün Çağlıyan G, Baştürk A, Aras MR, Demircioğlu S, Turgut B, Merter M, Kabukçu Hacıoğlu S, Bağcı M, Albayrak M, Korkmaz S, Erkurt MA, Dal MS, Ersoy Dursun F, Tombak A, Aydoğdu İ, Ulaş T, Altuntaş F. A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera. İstanbul Med J 2023; 24(2): 120-5. 1University of Health Sciences Turkey, İstanbul Training and Research Hospital, Clinic of Hematology, İstanbul, Turkey 2İstinye University, Liv Hospital Ulus, Clinic of Hematology, İstanbul, Turkey 3University of Health Sciences Turkey, Gazi Yaşargil Training and Research Hospital, Clinic of Hematology, Diyarbakır, Turkey 4Pamukkale University Faculty of Medicine, Department of Hematology, Denizli, Turkey 5Medicana International İstanbul Hospital, İstanbul, Turkey 6University of Health Sciences Turkey, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Clinic of Hematology, Ankara, Turkey 7Necmettin Erbakan University, Meram Faculty of Medicine, Department of Hematology, Konya, Turkey 8Namık Kemal University Faculty of Medicine, Department of Hematology, Tekirdağ, Turkey 9Fırat University Faculty of Medicine, Department of Hematology, Elazığ, Turkey 10Selçuk University Faculty of Medicine, Department of Hematology, Konya, Turkey 11University of Health Sciences Turkey, Kayseri City Training and Research Hospital, Clinic of Hematology and Apheresis Unit, Kayseri, Turkey 12İnönü University Faculty of Medicine, Department of Hematology, Malatya, Turkey 13University of Health Sciences Turkey, Ankara Oncology Training and Research Hospital, Clinic of Hematology and Apheresis Unit, Ankara, Turkey 14İstanbul Medeniyet University, Göztepe Training and Research Hospital, Clinic of Hematology, İstanbul, Turkey 15Mersin University Faculty of Medicine, Department of Hematology, Mersin, Turkey 16Manisa Celal Bayar University Faculty of Medicine, Department of Hematology, Manisa, Turkey 17Near East University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Lefkoşa, Cyprus 18Ankara Yıldırım Beyazıt University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Turkey","PeriodicalId":42584,"journal":{"name":"Istanbul Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41983093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-31DOI: 10.4274/imj.galenos.2023.47717
Gülçin Şahingöz Erdal, Dilay Karabulut, C. Yıldız, Fatma Nihan Turhan Çağlar, M. Satılmışoğlu, M. Koşer, P. Kasapoğlu, N. Isiksacan
Methods
方法
{"title":"The role of h-FABP and Myoglobin in Determining Disease Severity and Prognosis in STEMI","authors":"Gülçin Şahingöz Erdal, Dilay Karabulut, C. Yıldız, Fatma Nihan Turhan Çağlar, M. Satılmışoğlu, M. Koşer, P. Kasapoğlu, N. Isiksacan","doi":"10.4274/imj.galenos.2023.47717","DOIUrl":"https://doi.org/10.4274/imj.galenos.2023.47717","url":null,"abstract":"Methods","PeriodicalId":42584,"journal":{"name":"Istanbul Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41986821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：